相似文献
1
Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.流感疫苗在老年人、儿童和孕妇群体中的负担、有效性及安全性。
Ther Adv Vaccines Immunother. 2019 Feb 7;7:2515135519826481. doi: 10.1177/2515135519826481. eCollection 2019.
2
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南（2021—2022年）》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
3
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南（2020—2021年）》
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Oct 6;54(10):1035-1059. doi: 10.3760/cma.j.cn112150-20200911-01198.
4
[Technical guidelines for seasonal influenza vaccination in China (2023-2024)].《中国季节性流感疫苗接种技术指南（2023—2024年）》
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Oct 10;44(10):1507-1530. doi: 10.3760/cma.j.cn112338-20230908-00139.
5
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南（2022—2023年）》
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544. doi: 10.3760/cma.j.cn112338-20220825-00734.
6
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南（2022—2023年）》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
7
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南（2020—2021年）》
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1555-1576. doi: 10.3760/cma.j.cn112338-20200904-01126.
8
[Technical guidelines for seasonal influenza vaccination in China, 2019-2020].《中国2019-2020年季节性流感疫苗接种技术指南》
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Nov 10;40(11):1333-1349. doi: 10.3760/cma.j.issn.0254-6450.2019.11.002.
9
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.疫苗预防和控制季节性流感：免疫实践咨询委员会的建议-美国，2022-23 流感季节。
MMWR Recomm Rep. 2022 Aug 26;71(1):1-28. doi: 10.15585/mmwr.rr7101a1.
10
[Technical guidelines for seasonal influenza vaccination in China (2018-2019)].《中国季节性流感疫苗接种技术指南（2018—2019年）》
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Nov 6;52(11):1101-1114. doi: 10.3760/cma.j.issn.0253-9624.2018.11.003.
引用本文的文献
1
A 14-year influenza reinfection surveillance in Chongqing, China: A retrospective analysis.中国重庆14年流感再感染监测：一项回顾性分析。
Hum Vaccin Immunother. 2025 Dec;21(1):2497576. doi: 10.1080/21645515.2025.2497576. Epub 2025 May 5.
2
Effectiveness of a theory-informed intervention to increase care home staff influenza vaccination rates: a cluster randomised controlled trial.一项基于理论的干预措施提高养老院工作人员流感疫苗接种率的有效性：一项整群随机对照试验。
J Public Health (Oxf). 2025 May 29;47(2):246-257. doi: 10.1093/pubmed/fdaf023.
3
Uncovering the Burden of Influenza-Associated Illness across Levels of Severity in the Kingdom of Saudi Arabia Across Three Seasons.揭示沙特阿拉伯王国三个季节中不同严重程度的流感相关疾病负担。
J Epidemiol Glob Health. 2025 Mar 20;15(1):47. doi: 10.1007/s44197-025-00390-1.
4
An mRNA vaccine candidate encoding cholera toxin subunit B and conserved antigens of influenza viruses confers cross-protection against influenza a viruses in adult and aged mice.一种编码霍乱毒素B亚基和流感病毒保守抗原的mRNA候选疫苗可在成年和老年小鼠中提供针对甲型流感病毒的交叉保护。
Hum Vaccin Immunother. 2025 Dec;21(1):2453304. doi: 10.1080/21645515.2025.2453304. Epub 2025 Feb 16.
5
Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention.流感疫苗的效果：一项荟萃分析揭示了在预防感染效果欠佳的情况下其对发病率的益处。
Eur Respir Rev. 2025 Jan 8;34(175). doi: 10.1183/16000617.0144-2024. Print 2025 Jan.
6
Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland.初级保健中流感疫苗对有症状流感的有效性：爱尔兰2022/2023和2023/2024两个流感季节的检测阴性病例对照研究
Influenza Other Respir Viruses. 2024 Dec;18(12):e70023. doi: 10.1111/irv.70023.
7
Effectiveness of influenza vaccine among the population in Chongqing, China, 2018-2022: A test negative design-based evaluation.2018-2022 年中国重庆人群流感疫苗有效性：基于似然比检验的评估。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2376821. doi: 10.1080/21645515.2024.2376821. Epub 2024 Jul 18.
8
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine.全身初免-黏膜加强免疫显著提高了二价呼吸道合胞病毒-流感病毒载体疫苗的保护效力。
NPJ Vaccines. 2024 Jun 26;9(1):118. doi: 10.1038/s41541-024-00912-1.
9
Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh.孟加拉国选定的三级保健医院中高风险人群季节性流感疫苗接种的可接受性、成本效益和能力：一项研究方案。
BMC Public Health. 2024 Jan 20;24(1):242. doi: 10.1186/s12889-024-17724-6.
10
Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older.75岁及以上社区居住老年人中疫苗诱导的血凝抑制抗体滴度的季节间下降以及针对流感的既往体液免疫的影响因素
Immun Ageing. 2023 Jul 31;20(1):38. doi: 10.1186/s12979-023-00362-8.
本文引用的文献
1
Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.既往接种史与儿童接种活疫苗或灭活疫苗的流感疫苗效力的相关性。
JAMA Netw Open. 2018 Oct 5;1(6):e183742. doi: 10.1001/jamanetworkopen.2018.3742.
2
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults.一项关于新型佐剂疫苗在老年人中安全性的系统评价和荟萃分析。
Vaccine. 2018 Jul 5;36(29):4207-4214. doi: 10.1016/j.vaccine.2018.06.004. Epub 2018 Jun 6.
3
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season.更新：美国疾病预防控制中心关于使用四价活流感疫苗（LAIV4）的建议-2018-19 流感季。
MMWR Morb Mortal Wkly Rep. 2018 Jun 8;67(22):643-645. doi: 10.15585/mmwr.mm6722a5.
4
Narcolepsy Associated with Pandemrix Vaccine.与 Pandemrix 疫苗相关的发作性睡病。
Curr Neurol Neurosci Rep. 2018 Jun 1;18(7):43. doi: 10.1007/s11910-018-0851-5.
5
Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.MF59 佐剂四价流感病毒疫苗与非佐剂流感疫苗在儿童中的疗效、免疫原性和安全性评价：一项多中心、随机、对照、观察者盲、3 期临床试验。
Lancet Respir Med. 2018 May;6(5):345-356. doi: 10.1016/S2213-2600(18)30108-5. Epub 2018 Apr 6.
6
Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18.2017/18 年西班牙北部，三价流感疫苗在以流感 B 谱系错配为主的流行季节中的中期有效性。
Euro Surveill. 2018 Feb;23(7). doi: 10.2807/1560-7917.ES.2018.23.7.18-00057.
7
Impact of Timing of Influenza Vaccination in Pregnancy on Transplacental Antibody Transfer, Influenza Incidence, and Birth Outcomes: A Randomized Trial in Rural Nepal.妊娠期间流感疫苗接种时间对胎盘抗体转移、流感发病率和出生结局的影响：尼泊尔农村的一项随机试验。
Clin Infect Dis. 2018 Jul 18;67(3):334-340. doi: 10.1093/cid/ciy090.
8
Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.2017 - 18年季节性流感疫苗效力中期评估 - 美国，2018年2月
MMWR Morb Mortal Wkly Rep. 2018 Feb 16;67(6):180-185. doi: 10.15585/mmwr.mm6706a2.
9
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.2017/18 年流感疫苗效力的临时估计：2018 年 1 月加拿大甲型 H3N2 和乙型（山形）流感早期同时流行。
Euro Surveill. 2018 Feb;23(5). doi: 10.2807/1560-7917.ES.2018.23.5.18-00035.
10
Vaccines for preventing influenza in healthy children.用于预防健康儿童流感的疫苗。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004879. doi: 10.1002/14651858.CD004879.pub5.
Zotero 插件